Clinical Trials Directory

Trials / Completed

CompletedNCT01827826

Call-2-Health: Preventing Type II Diabetes

Translating the Diabetes Prevention Project (DPP) in a Health Maintenance Organization (HMO) Setting

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
47 (actual)
Sponsor
Kaiser Permanente · Academic / Other
Sex
All
Age
40 Years – 74 Years
Healthy volunteers
Accepted

Summary

It is estimated that 30 million U.S. adults will have type 2 diabetes by 2050. Contributing to this national trend is the obesity epidemic. Three randomized trials have demonstrated that intensive behavioral interventions can prevent or delay the onset of diabetes. The purpose of this pilot study is to inform a future randomized, controlled Phase III trial of a population-based, telephonic, exercise and weight loss intervention to translate the findings of the Diabetes Prevention Program into practice. The telephonic intervention will be compared to usual care (30 participants in each group). The investigators will deliver the intervention in 12 weekly, 20-minute calls, with four subsequent maintenance calls, for a total of 16 calls over 24 weeks. Study outcomes will be measured at baseline and at 12 and 24 weeks. For this planning grant the investigators do not have an overall hypothesis. The investigators' goal is to develop and test whether it is possible to do exercise and weight loss

Conditions

Interventions

TypeNameDescription
BEHAVIORALTelephonic intervention to prevent Diabetes Mellitus, Type 2Participants assigned to the intervention group received a total of 16 phone calls from the study interventionist over 24 weeks. The first 12 weeks was the intervention phase and calls were made weekly. The second 12 weeks was the maintenance phase and calls were made every 3 weeks. After 24 weeks, the investigators continued to follow this group for 52 weeks post-randomization, allowing half of the group to continue to receive monthly maintenance calls while the other half received no further calls. The study interventionist used behavior modification techniques to encourage intervention group participants to adopt healthy eating and exercise habits so that improvement might be seen in fasting glucose, glycated hemoglobin (HbA1c), weight, and waist/hip measurements.

Timeline

Start date
2010-07-01
Primary completion
2011-10-01
Completion
2012-06-01
First posted
2013-04-10
Last updated
2017-10-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01827826. Inclusion in this directory is not an endorsement.